Faqihi Fahimeh, Perri Rita, Chien Jimmy, Cho Jin-Gun, Milne Stephen, Bag Shopna, Gilroy Nicole, Wheatley John R, Kairaitis Kristina
Department of Respiratory and Sleep Medicine, Westmead Hospital, Sydney, New South Wales, Australia.
Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
PLoS One. 2025 May 14;20(5):e0322780. doi: 10.1371/journal.pone.0322780. eCollection 2025.
Internationally, socioeconomic disadvantage is related to severe outcomes of COVID-19. We investigated the impact of socioeconomic disadvantage on infection rates, hospitalisation, and in-hospital outcomes for COVID-19 with standardised medical care.
This retrospective cross-sectional study included SARS-CoV-2 PCR-confirmed patients ≥18 years, admitted to a major public hospital between January 2020 and December 2021. Severe COVID-19 outcomes were defined by a composite outcome of in-hospital death or other critical complications. A generalised linear regression model of demographic features, co-existing conditions, and socioeconomic status was used to determine the risks of the composite outcome.
Of 797,343 individuals ≥18 years in the health district, 50,906 (6.4%) were PCR-positive, and 1,962 were hospitalised. Compared with the whole health district population, infected individuals were younger (median [interquartile range] age 35 [25-48] years vs 42 [31-58] years) and from areas with the greatest socioeconomic disadvantage (34.4% vs 20%; both p < 0.0001). Hospitalised patients were older, with more females compared to the PCR-positive group (46 years [33-61], 53.5%, respectively; p < 0.001), and 51.2% were from postcodes with greatest socioeconomic disadvantage (p < 0.0001). The composite outcome occurred in 11.5%, with an in-hospital mortality of 3.8%. Higher risk of the composite outcome was observed in males (OR 1.72, 95% CI [1.26-2.42], p < 0.001), patients aged ≥ 65 years (OR 6.96, [3.3-14.6], p < 0.001), those with ≥ 4 comorbidities (OR 2.67, [1.54-4.63], p < 0.001), and unvaccinated patients (OR 1.57, [1.05-2.38], p < 0.05). The risk of composite outcome did not increase with socioeconomic disadvantage (OR 0.97, [0.68, 1.42], p = 0.64).
In the absence of capacity restraints, socioeconomic disadvantage was not associated with severe in-hospital outcomes in a well-resourced care environment despite increased rates of infection and hospitalisation. This highlights the impact of universally accessible, standardised, protocolised, high-quality in-hospital care in reducing the risk of adverse in-hospital outcomes in socioeconomically disadvantaged patients.
在国际上,社会经济劣势与新冠病毒病(COVID-19)的严重后果相关。我们调查了社会经济劣势对接受标准化医疗护理的COVID-19感染率、住院情况及住院结局的影响。
这项回顾性横断面研究纳入了2020年1月至2021年12月期间在一家大型公立医院住院的年龄≥18岁且经严重急性呼吸综合征冠状病毒2(SARS-CoV-2)聚合酶链反应(PCR)确诊的患者。严重COVID-19结局由住院死亡或其他严重并发症的复合结局定义。使用包含人口统计学特征、并存疾病和社会经济状况的广义线性回归模型来确定复合结局的风险。
在该健康区797,343名≥18岁的个体中,50,906人(6.4%)PCR检测呈阳性,其中1,962人住院。与整个健康区人群相比,感染个体更年轻(年龄中位数[四分位间距]为35[25 - 48]岁,而整体为42[31 - 58]岁),且来自社会经济劣势最严重地区(分别为34.4%和20%;均p < 0.0001)。住院患者年龄更大,与PCR阳性组相比女性更多(分别为46岁[33 - 61]岁、53.5%;p < 0.001),51.2%来自社会经济劣势最严重的邮政编码地区(p < 0.0001)。复合结局发生率为11.5%,住院死亡率为3.8%。在男性(比值比[OR]1.72,95%置信区间[CI][1.26 - 2.42],p < 0.001)、年龄≥65岁的患者(OR 6.96,[3.3 - 14.6],p < 0.001)、有≥4种合并症的患者(OR 2.67,[1.54 - 4.63],p < 0.001)以及未接种疫苗的患者(OR 1.57,[1.05 - 2.38],p < 0.05)中观察到复合结局风险更高。复合结局风险并未随社会经济劣势增加(OR 0.97,[0.68, 1.42],p = 0.64)。
在不存在能力限制的情况下,尽管感染率和住院率有所上升,但在资源充足的护理环境中,社会经济劣势与严重住院结局无关。这凸显了普遍可及、标准化、规范化、高质量的住院护理对降低社会经济劣势患者不良住院结局风险的影响。